Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
FerroAtlántica
GSM
$757M
| $19.9M | 0.04% |
1,125,157
+59,225
| +6% | +$1.18M |
|
627
Hanover Insurance
THG
$7.92B
| $19.9M | 0.04% |
269,004
+90,146
| +50% | +$6.48M |
|
628
PENN Entertainment
PENN
$2.45B
| $19.9M | 0.04% |
1,082,424
-356,637
| -25% | -$5.93M |
|
629
Oxford Industries
OXM
$546M
| $19.8M | 0.04% |
226,979
+95,168
| +72% | +$7.54M |
|
630
Pacific Biosciences
PACB
$398M
| $19.8M | 0.04% |
3,444,467
+1,275,560
| +59% | +$7.38M |
|
631
A.O. Smith
AOS
$8.52B
| $19.7M | 0.04% |
548,430
-59,106
| -10% | -$2.04M |
|
|
RLYP
632
DELISTED
RELYPSA INC COM
RLYP
| $19.7M | 0.04% |
596,414
+162,569
| +37% | +$5.59M |
|
633
Blackstone Mortgage Trust
BXMT
$2.38B
| $19.7M | 0.04% |
709,100
+678,937
| +2,251% | +$20.3M |
|
634
Williams-Sonoma
WSM
$28B
| $19.7M | 0.04% |
478,632
+94,910
| +25% | +$3.71M |
|
635
Belden
BDC
$4.56B
| $19.6M | 0.04% |
241,885
+180,032
| +291% | +$15.8M |
|
|
BMS
636
DELISTED
Bemis
BMS
| $19.6M | 0.04% |
+436,097
| New | +$20M |
|
637
Blackrock
BLK
$182B
| $19.6M | 0.04% |
+56,542
| New | +$20.6M |
|
|
RCAP
638
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| $19.5M | 0.04% |
2,550,488
-153,710
| -6% | -$1.25M |
|
639
Trane Technologies
TT
$99.7B
| $19.5M | 0.04% |
289,247
+171,323
| +145% | +$11.7M |
|
640
Middleby
MIDD
$5.21B
| $19.5M | 0.04% |
173,555
-145,667
| -46% | -$15.6M |
|
|
641
Altria Group
MO
$114B
| $19.5M | 0.04% |
397,815
-3,425,395
| -90% | -$174M |
|
|
EQY
642
DELISTED
Equity One
EQY
| $19.4M | 0.04% |
832,767
-411,053
| -33% | -$10.3M |
|
643
GSK
GSK
$104B
| $19.4M | 0.04% |
+372,387
| New | +$21M |
|
|
WFM
644
DELISTED
Whole Foods Market Inc
WFM
| $19.4M | 0.04% |
490,728
-513,751
| -51% | -$23M |
|
|
DYAX
645
DELISTED
DYAX CORPORATION
DYAX
| $19.4M | 0.04% |
730,210
-1,501,407
| -67% | -$39.8M |
|
646
Edison International
EIX
$28.5B
| $19.3M | 0.04% |
347,742
-167,843
| -33% | -$10.1M |
|
647
Hanmi Financial
HAFC
$926M
| $19.3M | 0.04% |
776,966
+223,413
| +40% | +$5M |
|
|
SOHU
648
Sohu.com
SOHU
$379M
| $19.2M | 0.04% |
325,756
+311,038
| +2,113% | +$20.2M |
|
|
SGYP
649
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $19.2M | 0.04% |
2,312,602
+2,141,766
| +1,254% | +$10.4M |
|
650
Cameco
CCJ
$44.5B
| $19.2M | 0.04% |
1,343,194
-1,081,111
| -45% | -$17.1M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.